AT266398T

Pharmaceutical compositions comprising tyrphostins

Abstract

For confrontation not hope some cell, organization or organ toxicity role of compounds, has type (ⅰ) of structure, which: Ar is structure type (I) or (ii) of group, n is 0, or Dang Ar is above structure type (I), is n also can is 1,R is CN,-C (s) NH2,-C (O) NHR3, or Dang R1 is 4-NO2,R2 is h or 3-OH Shi, is r also can is structure type (iii), (iv), (v), (vi) of group, R3 is h, phenyl-, phenyl (lower alkyl), or pyridine; R1 and R2 are independently H,OH,NO2, or when r is the CN, or a CH3,F, or CF3, when conditions are R1 and R2 are h.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

15 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
11906996IsraelA
9700276IsraelW

Members15

Family members, oldest first
DocumentOfficeKind
IL119069D0IsraelD0
CA2263325A1CanadaA1
WO9806391A1World Intellectual Property Organization (WIPO)A1
AU3782297AAustraliaA
EP0923371A1European Patent Office (EPO)A1
CN1232392AChinaA
BR9711160ABrazilA
AU728672B2AustraliaB2
JP2001504085AJapanA
US6426366B1United States of AmericaB1
US2003013748A1United States of AmericaA1
EP0923371B1European Patent Office (EPO)B1
AT266398TThis recordAustriaT
ATE266398T1AustriaT1
DE69729104D1GermanyD1